# 18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants

> **NCT04852523** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 4 (actual)

## Conditions studied

- Pancreatitis, Graft
- Pancreatic Transplant Post-Transplant Dysfunction Rejection

## Interventions

- **DRUG:** 18F-fluciclovine

## Key facts

- **NCT ID:** NCT04852523
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-16
- **Primary completion:** 2022-10-06
- **Final completion:** 2022-10-06
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2024-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04852523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04852523, "18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04852523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*